DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Atgam (Equine Thymocyte Immune Globulin) - Current Clinical Trials

 
 



Atgam Related Clinical Trials

Sirolimus, Tacrolimus, Anti-Thymocyte Globulin, and Rituximab in Preventing Graft-versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant [Recruiting]

Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia [Recruiting]

Tacrolimus and ATG as GVHD Prophylaxis in Patients Undergoing Related Donor HSCT [Recruiting]

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma [Recruiting]

Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant [Recruiting]

Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant [Recruiting]

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome [Recruiting]

Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation [Recruiting]

Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia [Recruiting]

Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Recruiting]

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Recruiting]

Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer [Recruiting]

Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection [Recruiting]

High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant [Recruiting]

Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia [Recruiting]

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer [Recruiting]

Sirolimus, Tacrolimus, Antithymocyte Globulin, and Rituximab in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancers or Other Diseases Undergoing Donor Peripheral Blood Stem Cell Transplant [Recruiting]

Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment [Recruiting]

Fludarabine, Busulfan, and Antithymocyte Globulin Followed By Donor Stem Cell Transplant in Treating Young Patients With High-Risk Neuroblastoma That Has Relapsed or Not Responded to Treatment [Recruiting]

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome [Recruiting]

Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy [Recruiting]

Scleroderma Treatment With Autologous Transplant (STAT) Study [Recruiting]

Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia [Recruiting]

Horse ATG in Patients With AA or Low/Int-1 Risk MDS [Recruiting]

Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies [Recruiting]

SCT for Dyskeratosis Congenita or SAA [Recruiting]

Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma [Not yet recruiting]

Treosulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders [Recruiting]

Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis [Recruiting]

Belatacept Early Steroid Withdrawal Trial [Recruiting]

ATG-GCSF in New Onset Type 1 Diabetes [Not yet recruiting]

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Recruiting]

HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors [Recruiting]

Viral Infection in Haploidentical HSCT With ATG for Acute Graft-versus-host Disease Prophylaxis [Recruiting]

Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma [Recruiting]

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant [Recruiting]

Preemptive Therapy of GVHD [Recruiting]

Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases [Recruiting]

Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant [Recruiting]

Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies [Not yet recruiting]

Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies [Recruiting]

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014